Clinical Trial Update: A Phase I Study of LFA102 in Japanese Patients [Phase 1]

View source ↗

Summary

This update notes that a Phase I trial of LFA102 in Japanese patients has been completed, evaluating castration-resistant prostate cancer and advanced breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Castration-resistant Prostate Cancer

Drugs mentioned

• LFA102

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Castration-resistant Prostate Cancer, Advanced Breast Cancer | Phase 1 | Status: COMPLETED